Cadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS-Type, RAS-Mutated Metastatic Colorectal Cancer
Abroad (travel likely)RecruitingPHASE2
Conditions
Metastatic Colorectal Cancer · Microsatellite Stable Colorectal Carcinoma · RAS Mutation · Cadonilimab
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Zhongshan hosptial, Fudan University, Shanghai, China